187 related articles for article (PubMed ID: 21938481)
1. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.
Ohe JY; Kwon YD; Lee HW
Clin Oral Investig; 2012 Aug; 16(4):1153-9. PubMed ID: 21938481
[TBL] [Abstract][Full Text] [Related]
2. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
4. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
[TBL] [Abstract][Full Text] [Related]
5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
6. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.
Ribeiro V; Garcia M; Oliveira R; Gomes PS; Colaço B; Fernandes MH
J Cell Mol Med; 2014 Jan; 18(1):27-37. PubMed ID: 24373581
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
9. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.
Kim HK; Kim JH; Abbas AA; Yoon TR
Clin Orthop Relat Res; 2009 Dec; 467(12):3121-8. PubMed ID: 18665432
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model.
Zhu S; Häussling V; Aspera-Werz RH; Chen T; Braun B; Weng W; Histing T; Nussler AK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374546
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.
Kim YH; Kim GS; Jeong-Hwa B
Exp Mol Med; 2002 May; 34(2):145-51. PubMed ID: 12085990
[TBL] [Abstract][Full Text] [Related]
13. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
14. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
16. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates inhibit surface-mediated osteogenesis.
Lotz EM; Lohmann CH; Boyan BD; Schwartz Z
J Biomed Mater Res A; 2020 Aug; 108(8):1774-1786. PubMed ID: 32276287
[TBL] [Abstract][Full Text] [Related]
18. Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs.
Zhou Q; Zhao ZN; Cheng JT; Zhang B; Xu J; Huang F; Zhao RN; Chen YJ
Biochem Biophys Res Commun; 2011 Jan; 404(1):127-32. PubMed ID: 21108928
[TBL] [Abstract][Full Text] [Related]
19. Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors.
Vermeer JA; Jansen ID; Marthi M; Coxon FP; McKenna CE; Sun S; de Vries TJ; Everts V
Bone; 2013 Nov; 57(1):242-51. PubMed ID: 23962725
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human bone morphogenetic protein-2 on bisphosphonate-treated osteoblasts.
Kwon TK; Song JM; Kim IR; Park BS; Kim CH; Cheong IK; Shin SH
J Korean Assoc Oral Maxillofac Surg; 2014 Dec; 40(6):291-6. PubMed ID: 25551094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
